Trade CNSY stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cerenome, Inc. (CNSY) is trading at US$2.03, up 0.00% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$23.3M. Over the past 52 weeks, CNSY has traded between US$2.00 and US$23.43. On Syfe you can trade CNSY with $0 commission and add it to your watchlist.
| Previous close | US$2.03 |
|---|---|
| Market cap | US$23.3M |
| 52-week range | US$2.00 – US$23.43 |
| Volume | 60.18K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cerenome, Inc.
Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Year: 2000
Cerenome, Inc. (CNSY) stock is trading at US$2.03, 0.00% from the previous close of US$2.03.
The market cap for Cerenome, Inc. (CNSY) stock is approximately US$23.3M.
The 52-week high for Cerenome, Inc. (CNSY) stock is US$23.43.
The 52-week low for Cerenome, Inc. (CNSY) stock is US$2.00.
Cerenome, Inc. (CNSY) does not currently pay a dividend.
Stay on top of CNSY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
